CYP3A5 and epilepsy: The aim of the work of the team of Emich-Widera et al. [70] was an assessment of the relationship between CYP3A5 polymorphism and MDR1 C3435T polymorphism with focal drug-resistant epilepsy in children and adolescents up to 18 years of age.